ALKEMNSEAlkem Laboratories Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 13 Jun, 2025 · 15:26 IST

�Samprada & Nanhamati Singh Family Trust has submitted to exchange a copy of Disclosure with respect to Samprada and Nanhamati Singh Family Trust.

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.3%Reaction day
₹4836.00
prior close
₹4851.50
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.4%+0.7% vs market
Pharmaceuticals peers, median of 148sector-0.5%+0.8% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Midcap 150 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.3-0.4+0.7-0.5+0.8
Next day
+0.7+0.4+0.3-0.6+1.3
2d
-0.6-0.2-0.4-1.8+1.2
3d
-0.7-0.7-0.0-2.6+1.8
4d
-1.3-2.3+1.0-4.0+2.8
5d
-1.3-1.0-0.2-3.6+2.4
1w
-0.6+0.1-0.7-3.1+2.4
15d
+1.1+2.2-1.1-0.2+1.3
1m
+0.4+1.2-0.8-0.2+0.6
2m
+11.2-2.1+13.3-4.5+15.7
3m
+13.7+0.7+13.0-3.4+17.1
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Samprada & Nanhamati Singh Family Trust, part of the promoter group of Alkem Laboratories, sold 0.67% of the company's shares on June 11, 2025. Following this sale, the Trust's holding in Alkem has reduced from 19.41% to 18.74%. The proceeds from the sale were distributed to the beneficiaries of the Trust. The disclosure is being made under a SEBI exemption order dated March 10, 2017, which requires the Trust to report any changes in its shareholding. The Trust continues to remain a significant shareholder in the company post the transaction.

Likely market impact

This is a small reduction (less than 1%) in promoter group holding and is unlikely to materially affect the stock price. However, it indicates some monetisation by promoter-related entities, which retail investors may monitor for further reductions.